|Cris Calsada||Chief Financial Officer|
|Jay Hagan||President and Chief Executive Officer|
|Denis Drygin||Chief Scientific Officer|
|Brian Cheng||Cantor Fitzgerald|
|Yi Chen||H.C. Wainwright|
Good afternoon, ladies and gentlemen and welcome to the Regulus Therapeutics Inc. Quarter 3 2021 Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded. I’d now like to turn the conference over to your host, Ms. Cris Calsada, Chief Financial Officer.